Effect of different ratios of high and low molecular weight PLGA blend on the characteristics of pentamidine microcapsules

被引:44
作者
Graves, RA [1 ]
Pamujula, S [1 ]
Moiseyev, R [1 ]
Freeman, T [1 ]
Bostanian, LA [1 ]
Mandal, TK [1 ]
机构
[1] Xavier Univ, Coll Pharm, New Orleans, LA 70125 USA
关键词
PLGA; pentamidine; formulation; microcapsules; solvent evaporation; dissolution;
D O I
10.1016/j.ijpharm.2003.10.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two different PLGA samples (Resomer 502 and Resomer 506), either alone or in combinations, were used to prepare microcapsules. Microcapsules were prepared using a double emulsion solvent evaporation technique. The efficiency of encapsulation increased significantly when a mixture of I part Resomer 506 and 7 parts Resomer 502 was used to prepare the microcapsules. The efficiency of encapsulation of this batch was 23.7%, whereas the efficiency of encapsulations was only 13.9 and 9.8%, respectively, when the microcapsules were prepared with 100% Resomer 502 or 100% Resomer 506. In contrast, irrespective of the relative ratio of Resomer 502/Resomer 506, the median particle size of the microcapsules showed similar distribution pattern with the median size lies between 49 and 83 mum. The glass transition temperature (T-g) decreased significantly (44.6-25.5 degreesC) as the amount of Resomer 502 was increased in the formulation. The presence of Resomer 502 at lower concentration, along with Resomer 506, initially reduced the "burst effect." However, incorporation of a higher amount of Resomer 502 increased the "burst effect." Drug release from these microcapsules continued over 80 days. In conclusion, efficiency of encapsulation increased significantly when Resomer 506 was mixed with Resomer 502 at a ratio of 1:7. Blending of Resomer 502 with Resomer 506 reduced the glass transition temperature, which resulted in higher amount of drug release throughout the dissolution study. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:251 / 262
页数:12
相关论文
共 28 条
[1]   ENCAPSULATION OF WATER-SOLUBLE DRUGS BY A MODIFIED SOLVENT EVAPORATION METHOD .1. EFFECT OF PROCESS AND FORMULATION VARIABLES ON DRUG ENTRAPMENT [J].
ALEX, R ;
BODMEIER, R .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :347-355
[2]   Degradable polyphosphazene/poly(α-hydroxyester) blends:: degradation studies [J].
Ambrosio, AMA ;
Allcock, HR ;
Katti, DS ;
Laurencin, CT .
BIOMATERIALS, 2002, 23 (07) :1667-1672
[3]   Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl [J].
Birnbaum, DT ;
Brannon-Peppas, L .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2003, 14 (01) :87-102
[4]   THE BIODEGRADABILITY OF POLYESTER BLENDS [J].
CHA, Y ;
PITT, CG .
BIOMATERIALS, 1990, 11 (02) :108-112
[5]   Changes in cisplatin delivery due to surface-coated poly (lactic acid)-poly(ε-caprolactone) microspheres [J].
Chandy, T ;
Wilson, RF ;
Rao, GHR ;
Das, GS .
JOURNAL OF BIOMATERIALS APPLICATIONS, 2002, 16 (04) :275-291
[6]  
CHEN Y, 1994, MICROSPHERES REGIONA, P12
[7]   In vitro and in vivo degradation studies for development of a biodegradable patch based on poly(3-hydroxybutyrate) [J].
Freier, T ;
Kunze, C ;
Nischan, C ;
Kramer, S ;
Sternberg, K ;
Sass, M ;
Hopt, UT ;
Schmitz, KP .
BIOMATERIALS, 2002, 23 (13) :2649-2657
[8]   DEVELOPMENT OF INJECTABLE ANTITUMOR MICROSPHERES BASED ON POLYPHOSPHAZENE [J].
GOEDEMOED, JH ;
MENSE, EHG ;
DEGROOT, K ;
CLAESSEN, AME ;
SCHEPER, RJ .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (03) :245-257
[9]   PREPARATION AND CHARACTERIZATION OF POLY(EPSILON-CAPROLACTONE) POLYMER BLENDS FOR THE DELIVERY OF PROTEINS [J].
HUATAN, H ;
COLLETT, JH ;
ATTWOOD, D ;
BOOTH, C .
BIOMATERIALS, 1995, 16 (17) :1297-1303
[10]   Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends [J].
Jiang, WL ;
Schwendeman, SP .
PHARMACEUTICAL RESEARCH, 2001, 18 (06) :878-885